80 related articles for article (PubMed ID: 6805756)
1. Bromocriptine in management of large pituitary tumours.
Wass JA; Williams J; Charlesworth M; Kingsley DP; Halliday AM; Doniach I; Rees LH; McDonald WI; Besser GM
Br Med J (Clin Res Ed); 1982 Jun; 284(6333):1908-11. PubMed ID: 6805756
[TBL] [Abstract][Full Text] [Related]
2. Dopamine Agonists in the Management of Non-Functioning Pituitary Adenomas.
Capatina C; Poiana C
Acta Endocrinol (Buchar); 2021; 17(3):377-382. PubMed ID: 35342478
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hyperprolactinemia: a systematic review and meta-analysis.
Wang AT; Mullan RJ; Lane MA; Hazem A; Prasad C; Gathaiya NW; Fernández-Balsells MM; Bagatto A; Coto-Yglesias F; Carey J; Elraiyah TA; Erwin PJ; Gandhi GY; Montori VM; Murad MH
Syst Rev; 2012 Jul; 1():33. PubMed ID: 22828169
[TBL] [Abstract][Full Text] [Related]
4. Short-term treatment with cabergoline can lead to tumor shrinkage in patients with nonfunctioning pituitary adenomas.
Garcia EC; Naves LA; Silva AO; de Castro LF; Casulari LA; Azevedo MF
Pituitary; 2013 Jun; 16(2):189-94. PubMed ID: 22740242
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation and response to therapy in patients with massive prolactin hypersecretion.
Mascarell S; Sarne DH
Pituitary; 2007; 10(1):95-101. PubMed ID: 17308959
[TBL] [Abstract][Full Text] [Related]
6. Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function.
Sibal L; Ugwu P; Kendall-Taylor P; Ball SG; James RA; Pearce SH; Hall K; Quinton R
Pituitary; 2002; 5(4):243-6. PubMed ID: 14558672
[TBL] [Abstract][Full Text] [Related]
7. Receptor imaging in the diagnosis and treatment of pituitary tumors.
Kwekkeboom DJ; de Herder WW; Krenning EP
J Endocrinol Invest; 1999 Jan; 22(1):80-8. PubMed ID: 10090143
[No Abstract] [Full Text] [Related]
8. Nerve growth factor suppresses the transforming phenotype of human prolactinomas.
Missale C; Boroni F; Losa M; Giovanelli M; Zanellato A; Dal Toso R; Balsari A; Spano P
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7961-5. PubMed ID: 8367448
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic resistance in a case of invasive macroprolactinoma.
Schwarzstein D; García-Patterson A; Giménez G; Calaf J; Puig-Domingo M; Caixàs A; Matías-Guiu X; Webb SM
J Endocrinol Invest; 1993 Jun; 16(6):443-7. PubMed ID: 8103781
[TBL] [Abstract][Full Text] [Related]
10. Treatment of prolactinoma patients with the new non-ergot dopamine agonist roxindol: first results.
Jaspers C; Benker G; Reinwein D
Clin Investig; 1994 Jun; 72(6):451-6. PubMed ID: 7950157
[TBL] [Abstract][Full Text] [Related]
11. Two macroprolactinomas presenting with neurological signs.
Khan EG; Howlett TA
J R Soc Med; 1995 Feb; 88(2):111P-112P. PubMed ID: 7769587
[TBL] [Abstract][Full Text] [Related]
12. Acromegaly. Recognition and treatment.
Jaffe CA; Barkan AL
Drugs; 1994 Mar; 47(3):425-45. PubMed ID: 7514973
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology.
Nissim M; Ambrosi B; Bernasconi V; Giannattasio G; Giovanelli MA; Bassetti M; Vaccari U; Moriondo P; Spada A; Travaglini P; Faglia G
J Endocrinol Invest; 1982; 5(6):409-15. PubMed ID: 7169515
[No Abstract] [Full Text] [Related]
14. The effects of oral clonidine on the growth hormone level in acromegalic patients.
Gáspár L; Janáky T; Valkusz Z; László FA
J Endocrinol Invest; 1984 Aug; 7(4):327-9. PubMed ID: 6501804
[TBL] [Abstract][Full Text] [Related]
15. Treatment of prolactinomas with megavoltage radiotherapy.
Grossman A; Cohen BL; Charlesworth M; Plowman PN; Rees LH; Wass JA; Jones AE; Besser GM
Br Med J (Clin Res Ed); 1984 Apr; 288(6424):1105-9. PubMed ID: 6424752
[TBL] [Abstract][Full Text] [Related]
16. Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.
Breidahl HD; Topliss DJ; Pike JW
Br Med J (Clin Res Ed); 1983 Aug; 287(6390):451-2. PubMed ID: 6411170
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic bromocriptine administration on tumor size in patients with "nonsecreting" pituitary adenomas.
Verde G; Oppizzi G; Chiodini PG; Dallabonzana D; Luccarelli G; Liuzzi A
J Endocrinol Invest; 1985 Apr; 8(2):113-5. PubMed ID: 4031376
[TBL] [Abstract][Full Text] [Related]
18. Hormone-active intradural spinal metastasis of a prolactinoma--a case report.
Landgraf R; Rieder G; Schmiedek P; Clados D; Bise K; von Werder K
Klin Wochenschr; 1985 Apr; 63(8):379-84. PubMed ID: 3999624
[TBL] [Abstract][Full Text] [Related]
19. Rapid enlargement of non-functioning pituitary tumour following withdrawal of bromocriptine.
Clark JD; Wheatley T; Edwards OM
J Neurol Neurosurg Psychiatry; 1985 Mar; 48(3):287. PubMed ID: 3981206
[No Abstract] [Full Text] [Related]
20. Prolactinomas.
Grossman A; Besser GM
Br Med J (Clin Res Ed); 1985 Jan; 290(6463):182-4. PubMed ID: 3917745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
